Akers Biosciences Inc (NASDAQ:AKER) shares passed above its 50-day moving average during trading on Thursday . The stock has a 50-day moving average of $0.44 and traded as high as $0.47. Akers Biosciences shares last traded at $0.46, with a volume of 5,472 shares.

The company’s fifty day simple moving average is $0.44 and its 200 day simple moving average is $0.66.

An institutional investor recently raised its position in Akers Biosciences stock. Candriam Luxembourg S.C.A. boosted its stake in Akers Biosciences Inc (NASDAQ:AKER) by 19.5% in the 1st quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 388,220 shares of the medical instruments supplier’s stock after buying an additional 63,221 shares during the period. Candriam Luxembourg S.C.A. owned 3.11% of Akers Biosciences worth $377,000 at the end of the most recent reporting period. 9.25% of the stock is currently owned by institutional investors and hedge funds.

Akers Biosciences Company Profile (NASDAQ:AKER)

Akers Biosciences, Inc, together with its subsidiaries, develops, manufactures, and supplies rapid screening and testing products designed to deliver healthcare information to healthcare providers and consumers in the United States, the People's Republic of China, and internationally. The company's marketed products include BreathScan, a disposable breath alcohol detector; BreathScan PRO, a quantitative breath alcohol detection system; METRON, a disposable breath ketone device to monitor ketosis; and BreathScan Lync, a non-invasive, quantitative measurement of biological markers for health and wellness.

See Also: Hedge Funds – Risk or Reward?

Receive News & Ratings for Akers Biosciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Akers Biosciences and related companies with MarketBeat.com's FREE daily email newsletter.